Figure 4.

Effect of levosimendan on cerebral infarct size. Differences between infarct volume of the striatal and cortical parts of each slice were illustrated (A). A representative slice (slice number 3) after staining with triphenyltetrazolium chloride from a control animal (B) and a levosimendan-treated animal (C). The arrows indicate sites of infarct size reduction (* p < 0.05 from analysis of variance for repeated measurements).